EORTC 26101

• Research type

  Research Study

• Full title

  Phase III trial exploring the combination of bevacizumab and lomustine in patients with first recurrence of a glioblastoma.

• IRAS ID

  147233

• Contact name

  Sarah Jefferies

• Contact email

  sarah.jefferies@addenbrookes.nhs.uk

• Sponsor organisation

  European Organisation for Research and Treatment of Cancer (EORTC)

• Eudract number

  2010-023218-30

• Clinicaltrials.gov Identifier

  NCT01290939

• REC name

  East of England - Cambridge South Research Ethics Committee

• REC reference

  14/EE/0105

• Date of REC Opinion

  2 Jun 2014

• REC opinion

  Further Information Favourable Opinion